Net Income

A new fund combines nuclear energy and AI tech, betting that one can solve the other's massive power problem. But is it a brilliant strategy or a risky gamble?

A new service promises to decode and counter viral misinformation in 24 hours, offering brands a rapid-response weapon in the age of digital deception.

GBT Technologies' subsidiary is rolling out smart wellness hubs at universities, but can this tech-forward strategy overcome its parent's deep financial troubles?

The spatial biology leader will unveil its roadmap at AGBT 2026, targeting the next frontiers of drug discovery with 3D imaging and human-relevant models.

SUSE's strategic purchase of Losant aims to create the first full-stack, open-source IIoT platform, challenging proprietary giants at the 'tiny edge'.

Sequel Med Tech and Senseonics launch a groundbreaking system pairing a year-long glucose monitor with an automated insulin pump, reshaping daily life for many.

As it heads to key conferences, Orchestra BioMed is pitching its novel pacemaker-based hypertension treatment and a unique drug-eluting balloon.

Xtreme One Entertainment's OTCQB uplist signals a new era for its XFC brand, aiming to boost investor trust and fund its 'minor league' MMA growth.

As federal funding dwindles and supply costs soar, universities are adopting AI procurement solutions like Labviva to protect the future of scientific discovery.

Cloud security leader Zscaler prepares for high-stakes investor conferences, aiming to showcase its financial strength and AI-driven growth strategy.

ESOA raises $20M in a public offering, eyeing acquisitions amid soaring demand for energy infrastructure driven by AI, LNG exports, and grid modernization.

The virtual care provider extends its specialized behavioral health services for Medicare patients to Arizona, Illinois, and Indiana amid a provider shortage.

Travelzoo's Q4 revenue grew 9%, but profits evaporated as it invests heavily in its new subscription model. Is this a winning long-term strategy?

Clene Inc. faces investors with promising data for ALS and MS, but a looming cash crunch makes its upcoming conference a critical test of survival.

Innoviva prepares for a key investor conference, spotlighting its shift to specialty drugs and navigating questions on its diversified growth strategy.

TUDOR answers enthusiast calls with a new 36mm Ranger and a striking 'Dune white' dial, blending vintage appeal with modern technical prowess.

FinTech leader Derivative Path promotes Zack Nagelberg to President, signaling a strategic push into AI-driven risk management for evolving capital markets.

Princeton NuEnergy hires a battery industry titan to spearhead its commercial push, aiming to dominate the booming U.S. battery recycling market.

Reunion Neuroscience hits the investor conference circuit, seeking capital to advance its groundbreaking psychedelic-inspired therapies for depression and anxiety.

The suburban office REIT has extended key debt maturities and lowered borrowing costs, signaling lender confidence and positioning it for strategic growth.